(Q40327891)

19 September 2017

title

Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models (English)

1 reference

19 September 2017

Terada K

1

1 reference

19 September 2017

Wakimoto H

2

1 reference

19 September 2017

Tyminski E

3

1 reference

19 September 2017

Chiocca EA

4

1 reference

19 September 2017

Saeki Y

5

1 reference

19 September 2017

publication date

1 April 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

13

1 reference

19 September 2017

issue

8

1 reference

19 September 2017

page(s)

705-714

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302717

19 September 2017

exact match

0 references

cites work

Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Reovirus therapy of tumors with activated Ras pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

RNA viruses as virotherapy agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Oncolytic herpes simplex virus vectors for cancer virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Systemic antitumor immunity in experimental brain tumor therapy using a multimutated, replication-competent herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Bioluminescent indicators in living mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Optical imaging of Renilla luciferase reporter gene expression in living mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Advances in in vivo bioluminescence imaging of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

In vivo bioluminescence imaging for integrated studies of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

MRI of transgene expression: correlation to therapeutic gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Homologous recombination based modification in Escherichia coli and germline transmission in transgenic mice of a bacterial artificial chromosome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Versatile insertion plasmids for targeted genome manipulations in bacteria: isolation, deletion, and rescue of the pathogenicity island LEE of the Escherichia coli O157:H7 genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Release of initiation control by a mutational alteration in the R6K pi protein required for plasmid DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Construction of large DNA segments in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

Transient expression of SV 40 large T antigen by Cre/LoxP-mediated site-specific deletion in primary human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

In vivo tracking of neural progenitor cell migration to glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

inferred from DOI database lookup

7 January 2021

based on heuristic

An infectious transfer and expression system for genomic DNA loci in human and mouse cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

inferred from DOI database lookup

7 January 2021

based on heuristic

An enhanced packaging system for helper-dependent herpes simplex virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302717

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302717

1 reference

Dimensions Publication ID

19 September 2017

1015248857

0 references

1 reference